APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Live Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Swine Live Vaccine Industry Growth and Trends Forecast to 2032

31 December 2025101 pages

Choose your research edition.

Industry ResearchSwine Live Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Live Vaccine Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Swine Live Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Live Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Live Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Swine Live Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Live Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Swine Live Vaccine include Boehringer Ingelheim, Ceva Corporate, KM Biologics, Nisseiken, DHN, Harbin Pharmaceutical Group Bio-vaccine, Jinyu Biotechnology, Qindao Lijian Bio-Tech and Shenzhen BIOCBD Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Swine Live Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Swine Live Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Swine Live Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Swine Live Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Swine Live Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Swine Live Vaccine Market by Company

Boehringer Ingelheim

Ceva Corporate

KM Biologics

Nisseiken

DHN

Harbin Pharmaceutical Group Bio-vaccine

Jinyu Biotechnology

Qindao Lijian Bio-Tech

Shenzhen BIOCBD Biotechnology

Wuhan Keqian Biology

Zhongmu Industry

Swine Live Vaccine Segment by Type

Swine Fever Vaccine

Porcine Reproductive and Respiratory Syndrome Vaccine

Pseudorabies Vaccine

Others

Swine Live Vaccine Segment by Application

Breeding Farm

Veterinary Clinic

Swine Live Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Live Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Live Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Live Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Live Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Swine Live Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Swine Fever Vaccine Table 2. Major Company of Porcine Reproductive and Respiratory Syndrome Vaccine Table 3. Major Company of Pseudorabies Vaccine Table 4. Major Company of Others Table 5. Global Swine Live Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 7. Global Swine Live Vaccine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Swine Live Vaccine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Swine Live Vaccine Sales Market Share in Value by Type (2021-2026) Table 10. Global Swine Live Vaccine Price by Type (2021-2026) & (US$/Unit) Table 11. Global Swine Live Vaccine Sales by Type (2027-2032) & (K Units) Table 12. Global Swine Live Vaccine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Swine Live Vaccine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Swine Live Vaccine Sales Market Share in Value by Type (2027-2032) Table 15. Global Swine Live Vaccine Price by Type (2027-2032) & (US$/Unit) Table 16. North America Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 17. North America Swine Live Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Europe Swine Live Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Swine Live Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Latin America Swine Live Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Swine Live Vaccine Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Swine Live Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Swine Live Vaccine Industry Trends Table 27. Swine Live Vaccine Industry Drivers Table 28. Swine Live Vaccine Industry Opportunities and Challenges Table 29. Swine Live Vaccine Industry Restraints Table 30. Global Swine Live Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Swine Live Vaccine Revenue Market Share by Company (2021-2026) Table 32. Global Swine Live Vaccine Sales by Company (2021-2026) & (K Units) Table 33. Global Swine Live Vaccine Sales Share by Company (2021-2026) Table 34. Global Swine Live Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Swine Live Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Swine Live Vaccine Major Company Production Sites and Headquarters Table 37. Global Swine Live Vaccine Company, Product Type & Application Table 38. Global Swine Live Vaccine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Swine Live Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Swine Live Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Swine Live Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Swine Live Vaccine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Swine Live Vaccine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Swine Live Vaccine Sales Market Share in Value by Region (2021-2026) Table 46. Global Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Swine Live Vaccine Sales by Region (2027-2032) & (K Units) Table 48. Global Swine Live Vaccine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Swine Live Vaccine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Swine Live Vaccine Sales Market Share in Value by Region (2027-2032) Table 51. Global Swine Live Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Swine Live Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 54. Global Swine Live Vaccine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Swine Live Vaccine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Swine Live Vaccine Sales Market Share in Value by Application (2021-2026) Table 57. Global Swine Live Vaccine Price by Application (2021-2026) & (US$/Unit) Table 58. Global Swine Live Vaccine Sales by Application (2027-2032) & (K Units) Table 59. Global Swine Live Vaccine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Swine Live Vaccine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Swine Live Vaccine Sales Market Share in Value by Application (2027-2032) Table 62. Global Swine Live Vaccine Price by Application (2027-2032) & (US$/Unit) Table 63. North America Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 64. North America Swine Live Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Europe Swine Live Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Swine Live Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Latin America Swine Live Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Swine Live Vaccine Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Swine Live Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Swine Live Vaccine Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Ceva Corporate Company Information Table 79. Ceva Corporate Business Overview Table 80. Ceva Corporate Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Ceva Corporate Swine Live Vaccine Product Portfolio Table 82. Ceva Corporate Recent Development Table 83. KM Biologics Company Information Table 84. KM Biologics Business Overview Table 85. KM Biologics Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. KM Biologics Swine Live Vaccine Product Portfolio Table 87. KM Biologics Recent Development Table 88. Nisseiken Company Information Table 89. Nisseiken Business Overview Table 90. Nisseiken Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Nisseiken Swine Live Vaccine Product Portfolio Table 92. Nisseiken Recent Development Table 93. DHN Company Information Table 94. DHN Business Overview Table 95. DHN Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. DHN Swine Live Vaccine Product Portfolio Table 97. DHN Recent Development Table 98. Harbin Pharmaceutical Group Bio-vaccine Company Information Table 99. Harbin Pharmaceutical Group Bio-vaccine Business Overview Table 100. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio Table 102. Harbin Pharmaceutical Group Bio-vaccine Recent Development Table 103. Jinyu Biotechnology Company Information Table 104. Jinyu Biotechnology Business Overview Table 105. Jinyu Biotechnology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Jinyu Biotechnology Swine Live Vaccine Product Portfolio Table 107. Jinyu Biotechnology Recent Development Table 108. Qindao Lijian Bio-Tech Company Information Table 109. Qindao Lijian Bio-Tech Business Overview Table 110. Qindao Lijian Bio-Tech Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio Table 112. Qindao Lijian Bio-Tech Recent Development Table 113. Shenzhen BIOCBD Biotechnology Company Information Table 114. Shenzhen BIOCBD Biotechnology Business Overview Table 115. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio Table 117. Shenzhen BIOCBD Biotechnology Recent Development Table 118. Wuhan Keqian Biology Company Information Table 119. Wuhan Keqian Biology Business Overview Table 120. Wuhan Keqian Biology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Wuhan Keqian Biology Swine Live Vaccine Product Portfolio Table 122. Wuhan Keqian Biology Recent Development Table 123. Zhongmu Industry Company Information Table 124. Zhongmu Industry Business Overview Table 125. Zhongmu Industry Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Zhongmu Industry Swine Live Vaccine Product Portfolio Table 127. Zhongmu Industry Recent Development Table 128. North America Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. North America Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 130. North America Swine Live Vaccine Sales Market Share by Country (2021-2026) Table 131. North America Swine Live Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 132. North America Swine Live Vaccine Sales Market Share Forecast by Country (2027-2032) Table 133. North America Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Swine Live Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Swine Live Vaccine Market Share by Country (2021-2026) Table 136. North America Swine Live Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Swine Live Vaccine Market Share Forecast by Country (2027-2032) Table 138. Europe Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Europe Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 140. Europe Swine Live Vaccine Sales Market Share by Country (2021-2026) Table 141. Europe Swine Live Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 142. Europe Swine Live Vaccine Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Swine Live Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Swine Live Vaccine Market Share by Country (2021-2026) Table 146. Europe Swine Live Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Swine Live Vaccine Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 150. Asia-Pacific Swine Live Vaccine Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Swine Live Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 152. Asia-Pacific Swine Live Vaccine Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Swine Live Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Swine Live Vaccine Market Share by Country (2021-2026) Table 156. Asia-Pacific Swine Live Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Swine Live Vaccine Market Share Forecast by Country (2027-2032) Table 158. Latin America Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Latin America Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 160. Latin America Swine Live Vaccine Sales Market Share by Country (2021-2026) Table 161. Latin America Swine Live Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 162. Latin America Swine Live Vaccine Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Swine Live Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Swine Live Vaccine Market Share by Country (2021-2026) Table 166. Latin America Swine Live Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Swine Live Vaccine Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Swine Live Vaccine Sales by Country (2021-2026) & (K Units) Table 170. Middle East and Africa Swine Live Vaccine Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Swine Live Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 172. Middle East and Africa Swine Live Vaccine Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Swine Live Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Swine Live Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Swine Live Vaccine Market Share by Country (2021-2026) Table 176. Middle East and Africa Swine Live Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Swine Live Vaccine Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Swine Live Vaccine Distributors List Table 181. Swine Live Vaccine Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Swine Live Vaccine Image Figure 2. Global Swine Live Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Live Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Live Vaccine Sales (2021-2032) & (K Units) Figure 5. Swine Fever Vaccine Image Figure 6. Global Swine Fever Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Porcine Reproductive and Respiratory Syndrome Vaccine Image Figure 8. Global Porcine Reproductive and Respiratory Syndrome Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Pseudorabies Vaccine Image Figure 10. Global Pseudorabies Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Swine Live Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Swine Live Vaccine Market Share by Type 2025 VS 2032 Figure 15. North America Swine Live Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. North America Swine Live Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Europe Swine Live Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Swine Live Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Swine Live Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Swine Live Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Swine Live Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Swine Live Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Swine Live Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Swine Live Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Swine Live Vaccine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Breeding Farm Image Figure 28. Global Breeding Farm Sales YoY Growth (2021-2032) & (K Units) Figure 29. Veterinary Clinic Image Figure 30. Global Veterinary Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Swine Live Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Swine Live Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Swine Live Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Swine Live Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Swine Live Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Swine Live Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Swine Live Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Swine Live Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Swine Live Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Swine Live Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Swine Live Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Swine Live Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Swine Live Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Swine Live Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Swine Live Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Swine Live Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Swine Live Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Swine Live Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Swine Live Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Swine Live Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Swine Live Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Swine Live Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Swine Live Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Swine Live Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Swine Live Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Swine Live Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Swine Live Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Swine Live Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Swine Live Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Swine Live Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Swine Live Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Swine Live Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Swine Live Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Swine Live Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Swine Fever Vaccine
  • Porcine Reproductive and Respiratory Syndrome Vaccine
  • Pseudorabies Vaccine
  • Others
Applications
  • Breeding Farm
  • Veterinary Clinic
Companies covered
  • Boehringer Ingelheim
  • Ceva Corporate
  • KM Biologics
  • Nisseiken
  • DHN
  • Harbin Pharmaceutical Group Bio-vaccine
  • Jinyu Biotechnology
  • Qindao Lijian Bio-Tech
  • Shenzhen BIOCBD Biotechnology
  • Wuhan Keqian Biology
  • Zhongmu Industry

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Live Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Swine Live Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Swine Live Vaccine Market by Type
  6. 1.3.1 Swine Fever Vaccine
  7. 1.3.2 Porcine Reproductive and Respiratory Syndrome Vaccine
  8. 1.3.3 Pseudorabies Vaccine
  9. 1.3.4 Others
  10. 1.4 Global Swine Live Vaccine Market Size by Type
  11. 1.4.1 Global Swine Live Vaccine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Swine Live Vaccine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Swine Live Vaccine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Swine Live Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Swine Live Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Swine Live Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Swine Live Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Swine Live Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Swine Live Vaccine Industry Trends
  2. 2.2 Swine Live Vaccine Industry Drivers
  3. 2.3 Swine Live Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Live Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Swine Live Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Swine Live Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Swine Live Vaccine Price (2021-2026)
  4. 3.4 Global Swine Live Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Live Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Swine Live Vaccine Company, Product Type & Application
  7. 3.7 Global Swine Live Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Live Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Live Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Live Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Live Vaccine Regional Status and Outlook
  1. 4.1 Global Swine Live Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Swine Live Vaccine Historic Market Size by Region
  3. 4.2.1 Global Swine Live Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Swine Live Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Swine Live Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Swine Live Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Swine Live Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Swine Live Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Swine Live Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Swine Live Vaccine by Application
  1. 5.1 Swine Live Vaccine Market by Application
  2. 5.1.1 Breeding Farm
  3. 5.1.2 Veterinary Clinic
  4. 5.2 Global Swine Live Vaccine Market Size by Application
  5. 5.2.1 Global Swine Live Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Swine Live Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Swine Live Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Swine Live Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Swine Live Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Swine Live Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Swine Live Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Swine Live Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Swine Live Vaccine Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Ceva Corporate
  8. 6.2.1 Ceva Corporate Company Information
  9. 6.2.2 Ceva Corporate Business Overview
  10. 6.2.3 Ceva Corporate Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ceva Corporate Swine Live Vaccine Product Portfolio
  12. 6.2.5 Ceva Corporate Recent Developments
  13. 6.3 KM Biologics
  14. 6.3.1 KM Biologics Company Information
  15. 6.3.2 KM Biologics Business Overview
  16. 6.3.3 KM Biologics Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 KM Biologics Swine Live Vaccine Product Portfolio
  18. 6.3.5 KM Biologics Recent Developments
  19. 6.4 Nisseiken
  20. 6.4.1 Nisseiken Company Information
  21. 6.4.2 Nisseiken Business Overview
  22. 6.4.3 Nisseiken Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nisseiken Swine Live Vaccine Product Portfolio
  24. 6.4.5 Nisseiken Recent Developments
  25. 6.5 DHN
  26. 6.5.1 DHN Company Information
  27. 6.5.2 DHN Business Overview
  28. 6.5.3 DHN Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 DHN Swine Live Vaccine Product Portfolio
  30. 6.5.5 DHN Recent Developments
  31. 6.6 Harbin Pharmaceutical Group Bio-vaccine
  32. 6.6.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
  33. 6.6.2 Harbin Pharmaceutical Group Bio-vaccine Business Overview
  34. 6.6.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio
  36. 6.6.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
  37. 6.7 Jinyu Biotechnology
  38. 6.7.1 Jinyu Biotechnology Company Information
  39. 6.7.2 Jinyu Biotechnology Business Overview
  40. 6.7.3 Jinyu Biotechnology Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jinyu Biotechnology Swine Live Vaccine Product Portfolio
  42. 6.7.5 Jinyu Biotechnology Recent Developments
  43. 6.8 Qindao Lijian Bio-Tech
  44. 6.8.1 Qindao Lijian Bio-Tech Company Information
  45. 6.8.2 Qindao Lijian Bio-Tech Business Overview
  46. 6.8.3 Qindao Lijian Bio-Tech Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio
  48. 6.8.5 Qindao Lijian Bio-Tech Recent Developments
  49. 6.9 Shenzhen BIOCBD Biotechnology
  50. 6.9.1 Shenzhen BIOCBD Biotechnology Company Information
  51. 6.9.2 Shenzhen BIOCBD Biotechnology Business Overview
  52. 6.9.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio
  54. 6.9.5 Shenzhen BIOCBD Biotechnology Recent Developments
  55. 6.10 Wuhan Keqian Biology
  56. 6.10.1 Wuhan Keqian Biology Company Information
  57. 6.10.2 Wuhan Keqian Biology Business Overview
  58. 6.10.3 Wuhan Keqian Biology Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Wuhan Keqian Biology Swine Live Vaccine Product Portfolio
  60. 6.10.5 Wuhan Keqian Biology Recent Developments
  61. 6.11 Zhongmu Industry
  62. 6.11.1 Zhongmu Industry Company Information
  63. 6.11.2 Zhongmu Industry Business Overview
  64. 6.11.3 Zhongmu Industry Swine Live Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zhongmu Industry Swine Live Vaccine Product Portfolio
  66. 6.11.5 Zhongmu Industry Recent Developments
7 North America by Country
  1. 7.1 North America Swine Live Vaccine Sales by Country
  2. 7.1.1 North America Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Swine Live Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Swine Live Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Swine Live Vaccine Market Size by Country
  6. 7.2.1 North America Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Swine Live Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Swine Live Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Swine Live Vaccine Sales by Country
  2. 8.1.1 Europe Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Swine Live Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Swine Live Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Swine Live Vaccine Market Size by Country
  6. 8.2.1 Europe Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Swine Live Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Swine Live Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Swine Live Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Swine Live Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Swine Live Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Swine Live Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Swine Live Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Swine Live Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Swine Live Vaccine Sales by Country
  2. 10.1.1 South America Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Swine Live Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Swine Live Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Swine Live Vaccine Market Size by Country
  6. 10.2.1 South America Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Swine Live Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Swine Live Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Swine Live Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Swine Live Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Swine Live Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Swine Live Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Swine Live Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Swine Live Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Swine Live Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Swine Live Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Swine Live Vaccine Value Chain Analysis
  2. 12.1.1 Swine Live Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Swine Live Vaccine Production Mode & Process
  7. 12.2 Swine Live Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Swine Live Vaccine Distributors
  10. 12.2.3 Swine Live Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst